Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tauopathies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07047963
What this trial is testing

Neuropsychological Evaluation in Intellectual Disability (ENDI)

Who this might be right for
Down Syndrome (Trisomy 21)NeuropsychologyCognitive Aging+2 more
Central Hospital, Nancy, France 40
Not applicableStudy completedNCT03382353
What this trial is testing

EMuNI Project: Multiple Nonpharmacological Interventions

Who this might be right for
Lifestyle Risk Reduction
IRCCS Centro San Giovanni di Dio Fatebenefratelli 120
Not applicableStudy completedNCT02709356
What this trial is testing

Medium Chain Triglycerides and Brain Metabolism in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Université de Sherbrooke 20
Not applicableEnded earlyNCT01658722
What this trial is testing

Retrieval of Patient Information After Discontinuation

Who this might be right for
Alzheimer's Disease
JANSSEN Alzheimer Immunotherapy Research & Development, LLC 169
Testing effectiveness (Phase 2)UnknownNCT01120002
What this trial is testing

Efficacy and Safety of Tamibarotene (OAM80) for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Osaka City University 50
Not applicableStudy completedNCT00908999
What this trial is testing

Functional Magnetic Resonance Imaging (fMRI) of Anosognosia in Amnestic Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)

Who this might be right for
AnosognosiaAlzheimer's DiseaseMild Cognitive Impairment
University of Wisconsin, Madison 60
Not applicableLooking for participantsNCT06584357
What this trial is testing

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

Who this might be right for
Mild Cognitive ImpairmentAlzheimer's DiseaseAlzheimer's Disease, Early Onset+3 more
GAP Innovations, PBC 1,200
Testing effectiveness (Phase 2)WithdrawnNCT04263519
What this trial is testing

A Pilot Open Labeled Study of Tacrolimus in Alzheimer's Disease.

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
Massachusetts General Hospital
Early research (Phase 1)Study completedNCT00551772
What this trial is testing

Assess The Pharmacokinetics Of SB-742457 Formulated As A Capsule And A Tablet In Healthy Elderly Volunteers.

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 12
Early research (Phase 1)Study completedNCT00480467
What this trial is testing

Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-315 in Healthy Japanese Males

Who this might be right for
Alzheimer Disease
Wyeth is now a wholly owned subsidiary of Pfizer 32
Not applicableStudy completedNCT04856072
What this trial is testing

Deep Brain Stimulation in Alzheimer's Disease: Biomarkers and Dose Optimization

Who this might be right for
Alzheimer Disease
University Health Network, Toronto 11
Not applicableStudy completedNCT02409030
What this trial is testing

Multi-parameter Diagnostic Blood Test for the Diagnosis of Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Raman Health Technologies, S.L. 700
Not applicableStudy completedNCT03076671
What this trial is testing

More Than a Movement Disorder: Applying Palliative Care to Parkinson's Disease

Who this might be right for
Parkinson DiseaseParkinsonismLewy Body Disease+8 more
University of Colorado, Denver 783
Post-approval studies (Phase 4)Study completedNCT01122329
What this trial is testing

A Positron Emission Tomography (PET) Study Evaluating Brain Metabolism of a Medical Food in Alzheimer's Disease

Who this might be right for
Alzheimer Disease
University of California, Los Angeles 17
Not applicableEnrolling By InvitationNCT07234851
What this trial is testing

Understanding Mechanisms of Synaptic Degeneration Underlying Clinical Symptoms in Patients With MDs and NDs.

Who this might be right for
Schizophrenia DisorderFrontotemporal Dementia, Behavioral VariantMajor Depressive Disorder (MDD)+2 more
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 150
Early research (Phase 1)Study completedNCT01125631
What this trial is testing

Multiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 8
Very early researchStudy completedNCT03926702
What this trial is testing

Tau Imaging With JNJ067

Who this might be right for
Alzheimer DiseaseMild Cognitive ImpairmentProgressive Supranuclear Palsy
University of California, Berkeley 18
Testing effectiveness (Phase 2)Study completedNCT01378195
What this trial is testing

ICare Stress Management e-Training for Dementia Family Caregivers

Who this might be right for
Alzheimer's DiseaseDementia
Photozig, Inc. 150
Not applicableStudy completedNCT02933177
What this trial is testing

Effectiveness of Flash Mediation Therapy

Who this might be right for
Dementia
Hospices Civils de Lyon 241
Not applicableStudy completedNCT01538212
What this trial is testing

Retrospective Cohort Study Of The Efficacy Of Axona® (Medium Chain Triglycerides) In Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Cerecin 55
Next Page